Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bruce Haffty, MD
Rutgers Cancer Institute of New Jersey
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arizona Breast Cancer
Gilbert, Arizona, United States
- University of California, San Diego
La Jolla, California, United States
- William Beaumont Hospital Research Institute
Royal Oak, Michigan, United States
- Rwjbarnabas Health - Robert Wood Johnson University Hospital
New Brunswick, New Jersey, United States
- Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- Montefiore Medical Center
The Bronx, New York, United States
- 21st Centry Oncolgy
Yonkers, New York, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Bryn Mawr Hospital
Bryn Mawr, Pennsylvania, United States
- Huntsman Cancer Hospital, University of Utah
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Jul 2015
- Primary completion
- 18 Aug 2017
- Completion
- 31 Mar 2021
- Last update posted
- 15 May 2023
- Registered enrollment
- 200
- Registry id
- NCT02526498
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.